• 4D Molecular Therapeutics Names Kristian Humer as CFO MarketScreener Mon, 17 Nov 2025 12:18:33 GMT
• 4D Molecular (FDMT) Therapeutics Appoints New CFO to Drive Finan GuruFocus Mon, 17 Nov 2025 11:36:53 GMT
• 4D Molecular Therapeutics Appoints New Chief Financial Officer TipRanks Mon, 17 Nov 2025 11:36:23 GMT
• 4D Molecular Therapeutics Appoints Kristian Humer as Chief Financial Officer Quiver Quantitative Mon, 17 Nov 2025 11:12:00 GMT
• 4D Molecular Therapeutics (Nasdaq: FDMT) names Kristian Humer CFO to lead finance Stock Titan Mon, 17 Nov 2025 11:00:00 GMT
• 4DMT Appoints Kristian Humer as Chief Financial Officer GlobeNewswire Mon, 17 Nov 2025 11:00:00 GMT
• Applying big data sentiment scoring on 4D Molecular Therapeutics Inc. - July 2025 Short Interest & Risk Controlled Daily Plans newser.com Sun, 16 Nov 2025 14:13:03 GMT
• can 4d molecular therapeutics inc. stock weather global recession - market activity recap & daily technical forecast reports newser.com Sun, 16 Nov 2025 00:08:27 GMT
• Is 4D Molecular Therapeutics Inc. stock ready for a breakout - 2025 Market Sentiment & Risk Managed Trade Strategies newser.com Sat, 15 Nov 2025 07:37:13 GMT
• Can 4D Molecular Therapeutics Inc. stock weather global recession - 2025 Trading Volume Trends & Community Verified Swing Trade Si... newser.com Sat, 15 Nov 2025 04:22:05 GMT
• can 4d molecular therapeutics inc. rally from current levels - market growth summary & free expert approved momentum trade ideas newser.com Sat, 15 Nov 2025 03:15:52 GMT
• how 4d molecular therapeutics inc. stock performs in rising dollar environment - 2025 geopolitical influence & ai driven price pre... newser.com Sat, 15 Nov 2025 00:26:28 GMT
• can 4d molecular therapeutics inc. rally from current levels - july 2025 setups & weekly high return forecasts newser.com Fri, 14 Nov 2025 21:55:00 GMT
• 4DMT (NASDAQ: FDMT) grants 45,400 RSUs to four new employees under 2025 inducement plan Stock Titan Fri, 14 Nov 2025 21:05:00 GMT
• Can 4D Molecular Therapeutics Inc. stock weather global recession - July 2025 WrapUp & Fast Gain Swing Alerts newser.com Fri, 14 Nov 2025 19:02:36 GMT
• can 4d molecular therapeutics inc. stock weather global recession - 2025 institutional moves & weekly watchlist for hot stocks newser.com Thu, 13 Nov 2025 11:49:08 GMT
• how 4d molecular therapeutics inc. stock performs in rising dollar environment - weekly risk report & ai forecast swing trade pick... newser.com Thu, 13 Nov 2025 02:15:03 GMT
• Promising Outlook for 4D Molecular Therapeutics: Buy Rating Backed by Strategic Partnerships and Strong Financial Position TipRanks Wed, 12 Nov 2025 12:19:04 GMT
• H.C. Wainwright Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Maintains Target Price $36 富途牛牛 Wed, 12 Nov 2025 11:31:00 GMT
• Institutional investors own a significant stake of 49% in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) simplywall.st Wed, 12 Nov 2025 10:30:29 GMT
• Barclays Maintains 4D Molecular Therapeutics (FDMT) Overweight Recommendation Nasdaq Wed, 12 Nov 2025 00:03:00 GMT
• rbc capital maintains 4d molecular therapeutics (fdmt) outperform recommendation Nasdaq Wed, 12 Nov 2025 00:03:00 GMT
• 4D Molecular Therapeutics stock price target raised by RBC to $32 on funding Investing.com Nigeria Tue, 11 Nov 2025 23:17:25 GMT
• Morgan Stanley Maintains 4D Molecular Therapeutics(FDMT.US) With Hold Rating 富途牛牛 Tue, 11 Nov 2025 14:33:01 GMT
• 4d molecular price target raised to $32 from $26 at rbc capital TipRanks Tue, 11 Nov 2025 14:31:40 GMT
• Chardan Lifts Price Target on 4D Molecular Therapeutics to $26 From $25, Keeps Buy Rating MarketScreener Tue, 11 Nov 2025 13:16:55 GMT
• RBC Raises Price Target on 4D Molecular Therapeutics to $32 From $26, Keeps Outperform, Speculative Risk MarketScreener Tue, 11 Nov 2025 11:41:57 GMT
• 4d molecular therapeutics: financial backing strengthens clinical pipeline prospects AD HOC NEWS Tue, 11 Nov 2025 11:13:04 GMT
• 4d molecular therapeutics, inc. (fdmt) reports q3 loss, lags revenue estimates sharewise.com Tue, 11 Nov 2025 06:56:17 GMT
• 4D Molecular Therapeutics Reports Strategic Gains in Q3 2025 TipRanks Tue, 11 Nov 2025 04:19:59 GMT
• can 4d molecular therapeutics inc. stock weather global recession - portfolio update summary & safe capital growth tips newser.com Tue, 11 Nov 2025 02:36:33 GMT
• Key facts: 4D Molecular Therapeutics Q3 revenue rises to $90K; Otsuka invests $85M TradingView Mon, 10 Nov 2025 20:03:42 GMT
• 4D Molecular Therapeutics Misses On Revenue But Secures New Funding Finimize Mon, 10 Nov 2025 14:44:15 GMT
• is 4d molecular therapeutics inc. stock ready for a breakout - 2025 major catalysts & weekly high return opportunities newser.com Mon, 10 Nov 2025 14:25:36 GMT
• 4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates Yahoo Finance Mon, 10 Nov 2025 14:15:02 GMT
• fdmt reports financial outlook with sufficient funding until lat GuruFocus Mon, 10 Nov 2025 13:46:27 GMT
• 4DMT Reports Third Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones GlobeNewswire Mon, 10 Nov 2025 13:00:00 GMT
• 4DMT (NASDAQ: FDMT) signs APAC license for 4D-150: $85M upfront, $50M+ cost sharing Stock Titan Mon, 10 Nov 2025 13:00:00 GMT
• how 4d molecular therapeutics inc. stock performs in rising dollar environment - market volume summary & low drawdown momentum tra... newser.com Sun, 09 Nov 2025 13:04:10 GMT
• 4D Molecular Therapeutics Closes $93.3 Million Stock Offering The Globe and Mail Sun, 09 Nov 2025 11:02:25 GMT
• can 4d molecular therapeutics inc. stock weather global recession - 2025 big picture & entry point confirmation signals newser.com Sun, 09 Nov 2025 07:48:44 GMT
• bofa securities maintains 4d molecular therapeutics(fdmt.us) with buy rating, maintains target price $31 富途牛牛 Sat, 08 Nov 2025 08:19:58 GMT
• evercore maintains 4d molecular therapeutics(fdmt.us) with buy rating, maintains target price $45 富途牛牛 Sat, 08 Nov 2025 07:21:36 GMT
• latham & watkins advises 4d molecular therapeutics on us$100 million offering of common stock and pre-funded warrants Legal Desire Media and Insights Sat, 08 Nov 2025 06:23:33 GMT
• 4D Molecular Therapeutics Inc expected to post a loss of 98 cents a share - Earnings Preview TradingView Fri, 07 Nov 2025 23:56:07 GMT
• 4dmt inks potential $962 million gene therapy licensing deal Longevity.Technology Fri, 07 Nov 2025 17:04:03 GMT
• evercore maintains 4d molecular therapeutics(fdmt.us) with buy rating, maintains target price $45 富途牛牛 Fri, 07 Nov 2025 15:34:00 GMT
• BofA Securities Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Maintains Target Price $31 富途牛牛 Fri, 07 Nov 2025 14:31:00 GMT
• Bullish Outlook on 4D Molecular Therapeutics’ 4D-150: Promising Long-term Efficacy, Safety, and Financial Strength Justify Buy Rat... TipRanks Fri, 07 Nov 2025 14:04:22 GMT
• morgan stanley upgrades 4d molecular therapeutics to equalweight from underweight MarketScreener Fri, 07 Nov 2025 12:54:34 GMT
• 4d molecular stock rating upgraded by morgan stanley on positive trial data Investing.com Fri, 07 Nov 2025 10:21:23 GMT
• can 4d molecular therapeutics inc. stock weather global recession - earnings overview summary & real-time chart pattern alerts newser.com Fri, 07 Nov 2025 09:16:25 GMT
• Watkins Advises 4D Molecular Therapeutics on US$100 Million Offering of Common Stock and Pre-Funded Warrants Latham & Watkins LLP Fri, 07 Nov 2025 08:00:00 GMT
• 4D Molecular Therapeutics Closes $93.3 Million Stock Offering TipRanks Fri, 07 Nov 2025 08:00:00 GMT
• 4D Molecular Therapeutics stock rises after pricing $100M offering MSN Fri, 07 Nov 2025 08:00:00 GMT
• latham watkins advises 4d molecular therapeutics on offering of common stock pre-funded warrants Latham & Watkins LLP Fri, 07 Nov 2025 08:00:00 GMT
• morgan stanley upgrades 4d molecular therapeutics(fdmt.us) to hold rating, announces target price $16 富途牛牛 Fri, 07 Nov 2025 00:31:00 GMT
• 4d molecular upgraded to equal weight from underweight at morgan stanley TipRanks Fri, 07 Nov 2025 00:20:31 GMT
• 4DMT (NASDAQ: FDMT) to join Jefferies London fireside chat Nov 18, 9:00 a.m. GMT Stock Titan Thu, 06 Nov 2025 21:05:00 GMT
• 4d molecular (fdmt) reports promising prism trial data for wet a GuruFocus Thu, 06 Nov 2025 19:52:30 GMT
• can 4d molecular therapeutics inc. rally from current levels - 2025 year in review & stepwise trade signal guides newser.com Thu, 06 Nov 2025 18:45:51 GMT
• 4dmt releases positive interim 1.5- to 3.5-year data from phase 1/2 prism trial Ophthalmology Times Thu, 06 Nov 2025 17:36:35 GMT
• 4d molecular therapeutics, inc. announces positive long-term data from phase 1/2 prism clinical trial in wet amd supporting 4d-150... MarketScreener Thu, 06 Nov 2025 14:06:51 GMT
• 4d molecular therapeutics stock rises after pricing $100m offering MSN Thu, 06 Nov 2025 13:39:24 GMT
• fdmt stock sees strong support from leerink in recent offerings GuruFocus Thu, 06 Nov 2025 12:45:55 GMT
• 4d molecular therapeutics : 150 business & prism wet amd long-term data update (46f46c) MarketScreener Thu, 06 Nov 2025 11:50:16 GMT
• how 4d molecular therapeutics inc. stock performs in rising dollar environment - watch list & consistent growth equity picks newser.com Thu, 06 Nov 2025 11:41:05 GMT
• Shares priced at $10.51 as 4D Molecular Therapeutics (NASDAQ: FDMT) sets $100M offering Stock Titan Thu, 06 Nov 2025 11:23:00 GMT
• 4d molecular therapeutics (nasdaq: fdmt) shows 2-year durability, 2.8% inflammation in study Stock Titan Thu, 06 Nov 2025 11:00:00 GMT
• 4D Molecular Therapeutics Reports Positive Interim Trial Results TipRanks Thu, 06 Nov 2025 08:00:00 GMT
• 4DMT Announces Positive Long-Term Data from Phase 1/2 PRISM Clinical Trial in Wet AMD Supporting 4D-150’s Potential as a Backbone ... Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
• 4DMT Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants GlobeNewswire Thu, 06 Nov 2025 08:00:00 GMT
• 4DMT to Participate in Jefferies 2025 London Healthcare Conference Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
• is 4d molecular therapeutics inc. stock ready for a breakout - 2025 trading volume trends & reliable price action trade plans newser.com Thu, 06 Nov 2025 03:48:04 GMT
• applying big data sentiment scoring on 4d molecular therapeutics inc. - earnings beat & free community consensus stock picks newser.com Wed, 05 Nov 2025 22:48:39 GMT
• 4d molecular therapeutics approaches pivotal week with renewed momentum AD HOC NEWS Wed, 05 Nov 2025 19:02:04 GMT
• 4d molecular therapeutics (fdmt) expected to announce earnings on wednesday MarketBeat Wed, 05 Nov 2025 12:06:59 GMT
• can 4d molecular therapeutics inc. stock resist sector downturns - 2025 price targets & smart swing trading techniques newser.com Wed, 05 Nov 2025 06:25:10 GMT
• how institutional ownership impacts 4d molecular therapeutics inc. stock - july 2025 endofmonth & reliable volume spike trade aler... newser.com Wed, 05 Nov 2025 00:35:19 GMT
• what recovery options are there for 4d molecular therapeutics inc. - july 2025 fed impact & fast entry high yield stock tips newser.com Wed, 05 Nov 2025 00:32:37 GMT
• how institutional ownership impacts 4d molecular therapeutics inc. stock - weekly gains report & real-time volume analysis newser.com Tue, 04 Nov 2025 23:30:55 GMT
• backtesting results for 4d molecular therapeutics inc. trading strategies - gap up & low risk high win rate stock picks newser.com Tue, 04 Nov 2025 23:13:26 GMT
• analysts’ top healthcare picks: select medical (sem), ptc therapeutics (ptct) The Globe and Mail Tue, 04 Nov 2025 16:07:30 GMT
• 4dmt and otsuka pharmaceutical partner on 4d-150 in the greater asia-pacific region Ophthalmology Times Tue, 04 Nov 2025 11:06:18 GMT
• why 4d molecular therapeutics inc. stock remains on watchlists - 2025 buyback activity & free long-term investment growth plans newser.com Tue, 04 Nov 2025 08:55:06 GMT
• 4dmt and otsuka ink deal worth $336 m to advance eye disease treatment in apac BioSpectrum Asia Tue, 04 Nov 2025 08:25:58 GMT
• 4d molecular therapeutics (fdmt) receives a sell from morgan stanley The Globe and Mail Tue, 04 Nov 2025 08:00:00 GMT
• can 4d molecular therapeutics inc. stock weather global recession - market sentiment review & risk adjusted buy/sell alerts newser.com Tue, 04 Nov 2025 07:39:17 GMT
• how institutional buying supports 4d molecular therapeutics inc. stock - 2025 biggest moves & verified momentum stock watchlist fcp.pa.gov.br Mon, 03 Nov 2025 22:45:15 GMT
• 4d molecular therapeutics advances phase 3 trial for vision loss treatment MSN Mon, 03 Nov 2025 20:29:19 GMT
• can 4d molecular therapeutics inc. stock weather global recession - july 2025 trends & long-term capital growth strategies newser.com Mon, 03 Nov 2025 14:09:36 GMT
• How Much Upside is Left in 4D Molecular Therapeutics (FDMT)? Wall Street Analysts Think 171.74% Zacks Investment Research Mon, 03 Nov 2025 14:06:39 GMT
• can 4d molecular therapeutics inc. rally from current levels - 2025 market overview & community consensus picks newser.com Mon, 03 Nov 2025 13:20:59 GMT
• 4d molecular therapeutics partners with otsuka pharmaceutical for asia-pacific rights to 4d-150 gene therapy geneonline.com Mon, 03 Nov 2025 10:03:21 GMT
• 4dmt and otsuka to advance eye disease treatment in apac Pharmaceutical Technology Mon, 03 Nov 2025 08:38:41 GMT
• applying big data sentiment scoring on 4d molecular therapeutics inc. - options play & free expert verified stock movement alerts newser.com Mon, 03 Nov 2025 07:18:15 GMT
• is 4d molecular therapeutics inc. stock ready for a breakout - quarterly profit report & long-term investment growth plans newser.com Mon, 03 Nov 2025 06:25:20 GMT
• why 4d molecular therapeutics inc. stock remains on watchlists - july 2025 closing moves & high yield stock recommendations newser.com Mon, 03 Nov 2025 03:41:43 GMT
• what recovery options are there for 4d molecular therapeutics inc. - 2025 dividend review & free real-time market sentiment alerts... newser.com Mon, 03 Nov 2025 01:27:10 GMT
• can volume confirm reversal in 4d molecular therapeutics inc. - entry point & precise buy zone identification newser.com Sun, 02 Nov 2025 22:38:39 GMT
• what recovery options are there for 4d molecular therapeutics inc. - weekly investment summary & stock timing and entry methods newser.com Sun, 02 Nov 2025 21:15:29 GMT
• backtesting results for 4d molecular therapeutics inc. trading strategies - trade analysis summary & safe swing trade setups newser.com Sun, 02 Nov 2025 07:20:48 GMT
• is 4d molecular therapeutics inc. stock ready for a breakout - trade entry summary & fast gaining stock strategy reports newser.com Sun, 02 Nov 2025 07:19:35 GMT
• can 4d molecular therapeutics inc. stock resist sector downturns - 2025 sector review & safe entry point alerts newser.com Sun, 02 Nov 2025 06:50:36 GMT
• why 4d molecular therapeutics inc. stock remains on watchlists - dollar strength & weekly top performers watchlists newser.com Sat, 01 Nov 2025 17:39:35 GMT
• applying big data sentiment scoring on 4d molecular therapeutics inc. - share buyback & safe swing trade setups newser.com Sat, 01 Nov 2025 16:48:11 GMT
• can 4d molecular therapeutics inc. stock resist sector downturns - ipo watch & community driven trade alerts newser.com Sat, 01 Nov 2025 10:20:15 GMT
• is 4d molecular therapeutics inc. stock ready for a breakout - 2025 technical patterns & expert approved momentum ideas newser.com Sat, 01 Nov 2025 09:53:06 GMT
• backtesting results for 4d molecular therapeutics inc. trading strategies - quarterly market summary & ai forecast for swing trade... newser.com Sat, 01 Nov 2025 05:59:48 GMT
• 4dmt sends eye disease asset’s asia rights to otsuka for $85m upfront BioSpace Fri, 31 Oct 2025 14:54:45 GMT
• 4dmt licenses eye gene therapy to otsuka in asia-pacific; arcus’ $250m offering Endpoints News Fri, 31 Oct 2025 14:45:00 GMT
• 4dmt secures $85 million otsuka deal to fund phase iii program The Pharma Letter Fri, 31 Oct 2025 12:17:33 GMT
• 4d molecular therapeutics (fdmt) stock: soars on $85m otsuka deal to expand 4d-150 across apac parameter.io Fri, 31 Oct 2025 11:35:31 GMT
• 4d molecular shares rise premarket on partnership with otsuka MarketScreener Fri, 31 Oct 2025 11:15:22 GMT
• what recovery options are there for 4d molecular therapeutics inc. - trade risk report & daily price action insights newser.com Fri, 31 Oct 2025 10:20:55 GMT
• 4d molecular (fdmt) forms key partnership with otsuka pharmaceutical GuruFocus Fri, 31 Oct 2025 10:08:12 GMT
• 4d molecular therapeutics, inc. enters into collaboration and license agreement with otsuka pharmaceutical co., ltd MarketScreener Fri, 31 Oct 2025 10:02:00 GMT
• 4d molecular announces 4d-150 license agreement with otsuka pharmaceutical TipRanks Fri, 31 Oct 2025 09:48:29 GMT
• can 4d molecular therapeutics inc. stock resist sector downturns - market activity report & free fast gain swing trade alerts newser.com Fri, 31 Oct 2025 08:34:07 GMT
• 4DMT eyes $420M deal from Otsuka, with cash aimed at retinal gene therapy's phase 3 plans Fierce Biotech Fri, 31 Oct 2025 07:00:00 GMT
• 4D Molecular Therapeutics stock rises on $85 million Otsuka deal Investing.com Fri, 31 Oct 2025 07:00:00 GMT
• 4D Molecular Therapeutics stock price target raised by Leerink Partners Investing.com Fri, 31 Oct 2025 07:00:00 GMT
• 4D Molecular Therapeutics Partners with Otsuka for APAC Market TipRanks Fri, 31 Oct 2025 07:00:00 GMT
• Otsuka nabs Asia-Pacific rights to 4DMT's retinal gene therapy for $85M FirstWord Pharma Fri, 31 Oct 2025 07:00:00 GMT
• 4d molecular therapeutics announces strategic partnership with otsuka for development of 4d-150 in asia-pacific markets Quiver Quantitative Fri, 31 Oct 2025 07:00:00 GMT
• how to build a dashboard for 4d molecular therapeutics inc. stock - dip buying & daily price action insights newser.com Fri, 31 Oct 2025 06:03:53 GMT
• 4dmt partners with otsuka for retinal disease therapy in asia-pacific Investing.com Nigeria Fri, 31 Oct 2025 04:03:30 GMT
• why 4d molecular therapeutics inc. stock remains on watchlists - quarterly profit review & smart allocation stock tips newser.com Fri, 31 Oct 2025 03:46:13 GMT
• 4dmt (nasdaq: fdmt) licenses 4d-150 to otsuka in apac; $85m upfront, $336m milestones Stock Titan Fri, 31 Oct 2025 03:08:11 GMT
• 4dmt announces exclusive license agreement with otsuka pharmaceutical co., ltd. for development and commercialization of 4d-150 in... Sahm Fri, 31 Oct 2025 03:00:00 GMT
• how institutional ownership impacts 4d molecular therapeutics inc. stock - treasury yields & daily chart pattern signal reports newser.com Fri, 31 Oct 2025 02:43:04 GMT
• what recovery options are there for 4d molecular therapeutics inc. - july 2025 analyst calls & real-time volume spike alerts newser.com Thu, 30 Oct 2025 16:34:26 GMT
• 4DMT Announces Exclusive License Agreement with Otsuka GlobeNewswire Thu, 30 Oct 2025 07:00:00 GMT
• backtesting results for 4d molecular therapeutics inc. trading strategies - july 2025 postearnings & community trade idea sharing ... newser.com Thu, 30 Oct 2025 06:09:49 GMT
• applying big data sentiment scoring on 4d molecular therapeutics inc. - 2025 dividend review & community supported trade ideas newser.com Thu, 30 Oct 2025 03:01:12 GMT
• how to build a dashboard for 4d molecular therapeutics inc. stock - july 2025 update & fast entry high yield tips newser.com Thu, 30 Oct 2025 02:16:36 GMT
4D Molecular Therapeutics, Inc(NASDAQ:FDMT) 
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has t...
Founded: 2013
CEO: David Kirn
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends